Structure-Activity Relationship of Capsaicin Analogs and Transient Receptor Potential Vanilloid 1-Mediated Human Lung Epithelial Cell Toxicity

被引:44
|
作者
Thomas, Karen C. [1 ]
Ethirajan, Manivannan [2 ]
Shahrokh, Kiumars [1 ]
Sun, Hao [1 ]
Lee, Jeewoo [4 ]
Cheatham, Thomas E., III [3 ]
Yost, Garold S. [1 ]
Reilly, Christopher A. [1 ]
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
[4] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
基金
美国国家卫生研究院; 新加坡国家研究基金会; 美国国家科学基金会;
关键词
ANALGESIC AGENTS; AGONIST ACTIVITY; NEUROGENIC INFLAMMATION; RESPIRATORY-DISEASES; TRPV1; ANTAGONISTS; MECHANISMS; ACTIVATION; REGION; DEATH; SENSITIVITY;
D O I
10.1124/jpet.110.178491
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Activation of intracellular transient receptor potential vanilloid-1 (TRPV1) in human lung cells causes endoplasmic reticulum (ER) stress, increased expression of proapoptotic GADD153 (growth arrest-and DNA damage-inducible transcript 3), and cytotoxicity. However, in cells with low TRPV1 expression, cell death is not inhibited by TRPV1 antagonists, despite preventing GADD153 induction. In this study, chemical variants of the capsaicin analog nonivamide were synthesized and used to probe the relationship between TRPV1 receptor binding, ER calcium release, GADD153 expression, and cell death in TRPV1-overexpressing BEAS-2B, normal BEAS-2B, and primary normal human bronchial epithelial lung cells. Modification of the 3-methoxy-4-hydroxybenzylamide vanilloid ring pharmacophore of nonivamide reduced the potency of the analogs and rendered several analogs mildly inhibitory. Correlation analysis of analog-induced calcium flux, GADD153 induction, and cytotoxicity revealed a direct relationship for all three endpoints in all three lung cell types for nonivamide and N-(3,4-dihydroxybenzyl) nonanamide. However, the N-(3,4-dihydroxybenzyl) nonanamide analog also produced cytotoxicity through redox cycling/reactive oxygen species formation, shown by inhibition of cell death by N-acetylcysteine. Molecular modeling of binding interactions between the analogs and TRPV1 agreed with data for reduced potency of the analogs, and only nonivamide was predicted to form a "productive" ligand-receptor complex. This study provides vital information on the molecular interactions of capsaicinoids with TRPV1 and substantiates TRPV1-mediated ER stress as a conserved mechanism of lung cell death by prototypical TRPV1 agonists.
引用
收藏
页码:400 / 410
页数:11
相关论文
共 50 条
  • [1] Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation
    Qiang Li
    Li Li
    Fei Wang
    Jian Chen
    Yu Zhao
    Peijian Wang
    Bernd Nilius
    Daoyan Liu
    Zhiming Zhu
    Pflügers Archiv - European Journal of Physiology, 2013, 465 : 1303 - 1316
  • [2] Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation
    Li, Qiang
    Li, Li
    Wang, Fei
    Chen, Jian
    Zhao, Yu
    Wang, Peijian
    Nilius, Bernd
    Liu, Daoyan
    Zhu, Zhiming
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2013, 465 (09): : 1303 - 1316
  • [3] Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis
    Ang, Seah-Fang
    Moochhala, Shabbir M.
    Bhatia, Madhav
    CRITICAL CARE MEDICINE, 2010, 38 (02) : 619 - 628
  • [4] Transient Receptor Potential Vanilloid 1 Expression Mediates Capsaicin-Induced Cell Death
    Ramirez-Barrantes, Ricardo
    Cordova, Claudio
    Gatica, Sebastian
    Rodriguez, Belen
    Lozano, Carlo
    Marchant, Ivanny
    Echeverria, Cesar
    Simon, Felipe
    Olivero, Pablo
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [5] Capsaicin-induced inhibition of platelet aggregation is not mediated by transient receptor potential vanilloid type 1
    Mittelstadt, Scott W.
    Nelson, Richard A.
    Daanen, Jerome F.
    King, Andrew J.
    Kort, Michael E.
    Kym, Philip R.
    Lubbers, Nathan L.
    Cox, Bryan F.
    Lynch, James J., III
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (01) : 94 - 97
  • [6] Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: Structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents
    Suh, YG
    Lee, YS
    Min, KH
    Park, OH
    Kim, JK
    Seung, HS
    Seo, SY
    Lee, BY
    Nam, YH
    Lee, KO
    Kim, HD
    Park, HG
    Lee, J
    Oh, U
    Lim, JO
    Kang, SU
    Kil, MJ
    Koo, JY
    Shin, SS
    Joo, YH
    Kim, JK
    Jeong, YS
    Kim, SY
    Park, YH
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5823 - 5836
  • [7] Chronic Tear Deficiency Sensitizes Transient Receptor Potential Vanilloid 1-Mediated Responses in Corneal Sensory Nerves
    Masuoka, Takayoshi
    Yamashita, Yuka
    Nakano, Katsuya
    Takechi, Kenshi
    Niimura, Takahiro
    Tawa, Masashi
    He, Qiang
    Ishizawa, Keisuke
    Ishibashi, Takaharu
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [8] Three-Dimensional Quantitative Structure-Activity Relationship Study of Transient Receptor Potential Vanilloid 1 Channel Antagonists Reveals Potential for Drug Design Purposes
    Gianibbi, Beatrice
    Visibelli, Anna
    Spinsanti, Giacomo
    Spiga, Ottavia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [9] Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide
    Luo, Dan
    Zhang, Yi-Wei
    Peng, Wei-Jie
    Peng, Jun
    Chen, Qing-Quan
    Li, Dai
    Deng, Han-Wu
    Li, Yuan-Jian
    REGULATORY PEPTIDES, 2008, 150 (1-3) : 66 - 72
  • [10] Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells
    Thomas, Karen C.
    Sabnis, Ashwini S.
    Johansen, Mark E.
    Lanza, Diane L.
    Moos, Philip J.
    Yost, Garold S.
    Reilly, Christopher A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (03): : 830 - 838